|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
Ray Dalio Warns of a Shifting Global Order Amid Trade and Debt Imbalances
Apr 29, 2025 at 06:52 pm

Ray Dalio, the billionaire founder of investment firm Bridgewater Associates, has issued a stark warning about a coming "big change in the world order."
In a recent post on LinkedIn, Dalio highlighted several key imbalances and trends that he believes are converging to drive a major realignment in the global economic and political landscape.
These shifts, ranging from unsustainable trade and capital imbalances to rising deglobalization and deteriorating relations between major powers, will have profound implications for investors, policymakers, and citizens around the world.
What Is Happening to The Global Economic Order?
Many exporters and importers are cutting back on their U.S. ties. They realize that the tariff disputes and broader tensions are unlikely to fully resolve.
Also, both U.S. and Chinese companies and investors, and those who rely on their trade relations, are making other plans to reduce interdependence.
This trend, which began with U.S.-China relations, is now affecting other global markets, capital flows, and even military alliances.
It's also becoming clear that the U.S. role as the world’s largest consumer of goods and issuer of debt is increasingly viewed as unsustainable.
The thinking that the U.S. will pay back its debt in an assumed-stable dollar is “simpleminded and flawed.”
As these imbalances worsen and deglobalization proceeds, the risks of financial and political disruption will grow.
We are approaching a point of no return in the global monetary system, domestic politics, and international relations.
Other countries are preparing by forging new economic and political links.
What Happens Next
With calm, analytical policymaking, these transitions can be managed constructively. We need cooperative rebalancing strategies, like the “3-Part, 3-Percent Solution” that I described in my book, How Countries Go Broke.
But the current path of conflict and volatility will lead to irreversible consequences.
Investors and policymakers should focus on these underlying shifts, not short-term market moves. They need thoughtful, coordinated responses to these historic changes.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































